Peptide Technologies
Ordered peptides from Peptide Technologies? Mail in a sample (US only) and let us test it.
Test my supplyPeptide Technologies' purity-focused record is strongest for Semaglutide, where identity, purity, and fill results are consistently within range. BPC-157 is the weak point with repeated purity misses and volatile same-batch results, while PT-141 is mixed; evidence is current but narrow and batch-to-batch confidence is limited.
We investigated who actually operates Peptide Technologies — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Peptide Technologies rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
6 Jan 2026 | Fail | BPC-157 Peptide Technologies | lab name | View COA | |||
20 Mar 2025 | Pass | Semaglutide Peptide Technologies | lab name | View COA | |||
20 Mar 2025 | Pass | BPC-157 Peptide Technologies | lab name | View COA | |||
16 Mar 2025 | Fail | PT-141 Peptide Technologies | lab name | View COA | |||
16 Mar 2025 | Pass | PT-141 Peptide Technologies | lab name | View COA | |||
3 Mar 2025 | Fail | BPC-157 Peptide Technologies | lab name | View COA | |||
2 Mar 2025 | Fail | BPC-157 Peptide Technologies | lab name | View COA | |||
2 Mar 2025 | Pass | BPC-157 Peptide Technologies | lab name | View COA | |||
28 Feb 2025 | Pass | Semaglutide Peptide Technologies | lab name | View COA | |||
28 Feb 2025 | Pass | Semaglutide Peptide Technologies | lab name | View COA | |||
About Peptide Technologies test results from Finnrick
Peptide Technologies is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 11 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Peptide Technologies peptides in this dataset are BPC-157 (5 tests), PT-141 (2 tests) and Semaglutide (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 11 recent tests.
Ordered peptides from Peptide Technologies? Mail in a sample (US only) and let us test it.
Test my supply